血清内皮抑制素对脓毒症临床预测价值的探索性研究

吴思佳, 陈韵竺, 高敏, 彭玥

湖南师范大学学报医学版 ›› 2026, Vol. 23 ›› Issue (2) : 35-40.

PDF(2561 KB)
PDF(2561 KB)
湖南师范大学学报医学版 ›› 2026, Vol. 23 ›› Issue (2) : 35-40.
临床医学

血清内皮抑制素对脓毒症临床预测价值的探索性研究

  • 吴思佳, 陈韵竺, 高敏, 彭玥
作者信息 +

An Exploratory Study on the Clinical Predictive Value of Serum Endostatin in Sepsis

  • WU Sijia, CHEN Yunzhu, GAO Min, PENG Yue
Author information +
文章历史 +

摘要

目的 探讨血清内皮抑制素(endostatin,ES)在脓毒症患者作为潜在诊断与判断预后指标的价值。方法 纳入2022年4月—2022年10月在本院重症医学科接受治疗的重症患者68人,其中脓毒症患者54人,非脓毒症患者14人,并纳入20名健康献血者作为对照。收集记录临床数据,并检测入重症监护室(intensive care unit,ICU)患者当天的血清ES、降钙素原、C反应蛋白水平进行比较分析。结果 与健康对照组相比,重症患者的血清ES水平高于健康对照组(中位数46.67 vs 3.80 ng/mL,P<0.001);而脓毒症组患者血清ES水平高于非脓毒症组(中位数43.13 vs 31.16 ng/mL,P<0.05)。进一步分析发现脓毒症患者血清ES水平与疾病严重程度显著相关,急性生理学与慢性健康状况评分系统Ⅱ(acute physiology and chronic health evaluation Ⅱ,APACHE Ⅱ)评分≥25分组与<25分组ES水平有显著差异(中位数58.64 vs 42.68 ng/mL,P<0.05)。受试者工作特征(receiver operating characteristic,ROC)曲线分析显示,入住ICU当日血清ES水平对患者90天死亡率具有预测价值(最佳临界值为76.15 ng/mL,敏感性77.8%,特异性90.8%,P<0.001)。结论 脓毒症患者入住ICU当天的血清ES水平与疾病严重程度和不良预后相关,未来有望成为预测脓毒症患者预后的良好标志物。

Abstract

Objective To explore the value of serum endostatin (ES) as a potential diagnostic and prognostic indicator in patients with sepsis. Methods A total of 68 critically ill patients treated in the intensive care unit of our hospital from April 2022 to October 2022 were included in the study, among whom 54 were sepsis patients and 14 were non-sepsis patients. Additionally, 20 healthy blood donors were included as controls. Clinical data were collected and recorded, and the levels of serum endostatin, procalcitonin, and C-reactive protein on the day of intensive care unit (ICU) admission were detected and compared. Results Endostatin levels were higher in ICU patients compared with healthy controls (median, 46.67 vs 3.80 ng/mL, P<0.001); while the serum endostatin level in the sepsis group was higher than that in the non-sepsis group (median 43.13 vs 31.16 ng/mL, P<0.05). Further analysis revealed that the serum endostatin level in sepsis patients was significantly correlated with the severity of the disease, a significant difference in serum endostain levels was observed between the group with acute physiology and chronic health evaluation Ⅱ (APACHE Ⅱ) score ≥ 25 and the group with<25(median 58.64 vs 42.68 ng/mL, P<0.05). Receiver operating characteristic curve (ROC) analysis showed that the serum endostatin level on the first day of admission to the ICU had predictive value for the 90-day mortality rate of patients (optimal cutoff value 76.15 ng/mL, sensitivity 77.8%, specificity 90.8%, P<0.001). Conclusion Plasma endostatin levels at ICU admission are associated with disease severity and mortality. It may be used as a marker to predict septic patients' prognosis.

关键词

内皮抑制素 / 脓毒症 / 重症监护病房 / 疾病严重程度 / 预后

Key words

endostatin / sepsis / intensive care unit / disease severity / prognosis

引用本文

导出引用
吴思佳, 陈韵竺, 高敏, 彭玥. 血清内皮抑制素对脓毒症临床预测价值的探索性研究[J]. 湖南师范大学学报医学版. 2026, 23(2): 35-40
WU Sijia, CHEN Yunzhu, GAO Min, PENG Yue. An Exploratory Study on the Clinical Predictive Value of Serum Endostatin in Sepsis[J]. Journal of Hunan Normal University(Medical Science). 2026, 23(2): 35-40
中图分类号: R459.7    R692   

参考文献

[1] O'REILLY MS, BOEHM T, SHING Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth[J]. Cell, 1997, 88(2): 277-285.
[2] COUSSENS L M, FINGLETON B, MATRISIAN L M.Matrix metalloproteinase inhibitors and cancer: trials and tribulations[J]. Science, 2002, 295(5564): 2387-2392.
[3] SZARVAS T, LÁSZLÓ V, VOM DORP F, et al. Serum endostatin levels correlate with enhanced extracellular matrix degradation and poor patients’ prognosis in bladder cancer[J]. Int J Cancer, 2012, 130(12): 2922-2929.
[4] SHARMA B K, SRINIVASAN R, KAPIL S, et al.Serum levels of angiogenic and anti-angiogenic factors: their prognostic relevance in locally advanced hepatocellular carcinoma[J]. Mol Cell Biochem, 2013, 383: 103-112.
[5] MO HY, LUO DH, QIU HZ, et al.Elevated serum endostatin levels are associated with poor survival in patients with advanced-stage nasopharyngeal carcinoma[J]. Clin Oncol, 2013, 25(5): 308-317.
[6] KANTOLA T, VǞYRYNEN JP, KLINTRUP K, et al. Serum endostatin levels are elevated in colorectal cancer and correlate with invasion and systemic inflammatory markers[J]. Br J Cancer, 2014, 111(8): 1605-1613.
[7] BOSMANN M, WARD P A.The inflammatory response in sepsis[J]. Trends immunol, 2013, 34(3): 129-136.
[8] PENG Y, GAO M, JIANG Y, et al.Angiogenesis inhibitor endostatin protects mice with sepsis from multiple organ dysfunction syndrome[J]. Shock, 2015, 44(4): 357-364.
[9] SINGER M, DEUTSCHMAN C S, SEYMOUR C W, et al.The third international consensus definitions for sepsis and septic shock (Sepsis-3)[J]. JAMA, 2016, 315(8): 801-810.
[10] MǞRTENSSON J, JONSSON N, GLASSFORD NJet al. Plasma endostatin may improve acute kidney injury risk prediction in critically ill patients[J]. Ann Intensive Care, 2016, 6(1): 6.
[11] GU J W, GADONSKI G, WANG J, et al.Exercise increases endostatin in circulation of healthy volunteers[J]. BMC physiol, 2004, 4: 2.
[12] MARTIN G S.Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes[J]. Expert Rev Anti Infect Ther, 2012, 10(6): 701-706.
[13] JIAO J, GAO M, ZHANG H, et al.Identification of potential biomarkers by serum proteomics analysis in rats with sepsis[J]. Shock, 2014, 42(1): 75-81.
[14] CICHY MC, ROCHA FGG, TRISTÃO VR, et al. Collagen XVIII/endostatin expression in experimental endotoxemic acute renal failure[J]. Braz J Med Biol Res, 2009, 42(12): 1150-1155.
[15] NISSINEN L, KÄHÄRI V M. Matrix metalloproteinases in inflammation[J]. Biochim Biophys Acta, 2014, 1840(8): 2571-2580.
[16] PERKINS GD, NATHANI N, RICHTER AG, et al.Type XVIII collagen degradation products in acute lung injury[J]. Crit Care, 2009, 13(2): R52.
[17] LEE W L, LILES W C.Endothelial activation, dysfunction and permeability during severe infections[J]. Curr Opin Hematol, 2011, 18(3): 191-196.
[18] ABDOLLAHI A, HAHNFELDT P, MAERCKER C, et al.Endostatin's antiangiogenic signaling network[J]. Mol cell, 2004, 13(5): 649-663.

基金

湖南省重点研发计划项目 “脓毒症致多器官功能障碍三级预防体系建立的关键技术研究”(2023SK2035); 长沙市自然科学基金项目“内皮抑制素通过自噬调控Treg代谢及功能介导脓毒症免疫反应的机制研究”(kq2502236)

PDF(2561 KB)

Accesses

Citation

Detail

段落导航
相关文章

/

〈 〉